Polaryx Therapeutics Inc. PLYX shares are up on Tuesday as the company has made significant strides in advancing its clinical programs. The positive movement follows the announcement that Polaryx has ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results